Literature DB >> 9468051

Preparation, characterization, and in vitro release of ibuprofen from AI2O3/PLA/PMMA composites.

M Vallet-Regí1, S Granado, D Arcos, M Gordo, M V Cabañas, C V Ragel, A J Salinas, A L Doadrio, J San Román.   

Abstract

The preparation, characterization, and in vitro release of Ibuprofen from Al2O3, poly(L-lactic acid) (PLLA), and polymethylmethacrylate (PMMA) composites are described. The release process of the anti-inflammatory drug after the immersion of composites in a buffered solution is analyzed. The rate of Ibuprofen release is related to the crystalline or amorphous form of the drug. The presence of a ceramic component, alpha-Al2O3, and a biodegradable polymer, PLLA, facilitates both Ibuprofen crystallization and drug release. In addition, these composite systems modulate the release of the stereoisomers R(-) and S(+) of the drug.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9468051     DOI: 10.1002/(sici)1097-4636(19980305)39:3<423::aid-jbm11>3.0.co;2-b

Source DB:  PubMed          Journal:  J Biomed Mater Res        ISSN: 0021-9304


  4 in total

Review 1.  Organic-inorganic composites for bone drug delivery.

Authors:  Chidambaram Soundrapandian; Biswanath Sa; Someswar Datta
Journal:  AAPS PharmSciTech       Date:  2009-10-20       Impact factor: 3.246

2.  Influence of ibuprofen addition on the properties of a bioactive bone cement.

Authors:  P P Lopes; M S Silva; M H V Fernandes
Journal:  J Mater Sci Mater Med       Date:  2013-05-16       Impact factor: 3.896

3.  Use of triethylcitrate plasticizer in the production of poly-L-lactic acid implants with different degradation times.

Authors:  S M N Scapin; D R M Silva; P P Joazeiro; M C Alberto-Rincon; R M Luciano; E A R Duek
Journal:  J Mater Sci Mater Med       Date:  2003-07       Impact factor: 3.896

4.  Similarities and differences in coatings for magnesium-based stents and orthopaedic implants.

Authors:  Jun Ma; Marc Thompson; Nan Zhao; Donghui Zhu
Journal:  J Orthop Translat       Date:  2014-04-05       Impact factor: 5.191

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.